Introduction {#sec1_1}
============

Excess body weight is a major public health concern. Globally, the mean BMI has increased since 1980 \[[@B1]\]. Between 1980 and 2008, individuals in Japan had a lower BMI than individuals in other high-income countries; the mean BMI of men increased from 22.1 to 23.5 kg/m^2^ and that of women from 21.3 to 23.3 kg/m^2^\[[@B1]\]. Obesity is associated with high mortality \[[@B2]\] and high incidence of cancer \[[@B3]\], cardiovascular disease \[[@B4]\], coronary heart disease \[[@B5],[@B6]\] and diabetes \[[@B6]\]. Since April 2008, a nationwide health screening and intervention programme specifically targeting metabolic syndrome \[[@B7]\] is routinely conducted in Japan; however, the obesity statistics have not improved \[[@B8]\].

Treatment of obesity and maintenance of weight loss are challenging. Previous studies have examined the short- and long-term effects of various behavioural weight loss interventions. Although both diet \[[@B9]\] and exercise interventions \[[@B10]\] are important for more effective weight loss, diet intervention is prioritized over exercise intervention because of its larger effect on short-term weight loss \[[@B11]\]. A meta-analysis of changes in BMI after weight loss phases suggested that approximately 0.02-0.03 kg/m^2^ of the weight lost per month is regained \[[@B9]\]. To attain successful weight loss maintenance, a few weight maintenance programmes have been developed \[[@B12],[@B13]\].

In a previous 6-month randomised controlled trial (RCT), we focused on providing educational materials (e.g., textbooks, notebooks and a pedometer) and implementing group-based support as effective individual components of a weight loss programme \[[@B14]\]. The weight lost in 6 months in the education-only group was 4.7 kg (95% confidence interval (CI) 3.7-5.7 kg) and was significantly larger than that in the control group (2.9 kg; 95% CI 1.9-3.9 kg), which was provided only a single motivational lecture. Weight loss in the group-based support group was 7.7 kg (95% CI 6.7-8.8 kg) and was significantly larger than that in the control and the education-only groups. The RCT provided evidence that both educational materials and group-based support were effective components of a weight loss programme. However, no weight loss maintenance was observed after the intervention period.

Thus, in the present study, we conducted a 2-year, non-interventional, observational follow-up and annual follow-up measurements for participants in the education-only and the group-based support groups. Due to ethical concerns, we provided group-based support to the control group after the 6-month intervention period and did not include them in the follow-up measurements. A certain amount of weight regain might be inevitable because of the absence of weight maintenance programmes. However, a recent study demonstrated the effectiveness of motivational interviewing intervention at 12 months post intervention \[[@B15]\]. If the superiority of group-based support is conserved during the maintenance phase, it could be an essential approach on both short-term and long-term bases. However, if such superiority is not observed, a weight maintenance programme might be essential to maintain the effect of group-based support; thus, the factors responsible for successful weight loss maintenance could be explored. Therefore, in this study, we conducted a 2-year follow-up study, after completion of the 6-month intervention period, to examine and compare the effects of group-based support and education-only on weight loss maintenance.

Material and Methods {#sec1_2}
====================

Study Design and Participants {#sec2_1}
-----------------------------

The randomised trial method has been previously described \[[@B14],[@B16]\], and the protocol was registered with the University Hospital Medical Information Network Clinical Trials Registry (UMIN000001259). In brief, we conducted a 30-month RCT comprising a 6-month intervention between April and October 2009 and a 2-year, follow-up non-intervention that continued until October 2011; the study was conducted at the Mito Kyodo General Hospital in Ibaraki, Japan. During the intervention phase, the participants were randomly assigned to one of the following 3 groups: control, education-only or group-based support. Considering an intervention-related group difference of 2.5 ± 4.0 kg in the amount of weight lost at the end of 6 months, a two-sided alpha value of 0.0167 (with a Bonferroni\'s adjustment for post hoc tests), a power of 80% and an average attrition rate of 10%, the required sample size was estimated to be more than 60 participants in each group (180 participants in total). Accordingly, 188 adults (145 women and 43 men) participated in the present study.

After the intervention phase had ended, the participants in the education-only and the group-based support groups underwent annual follow-up measurements during a 2-year follow-up period. Owing to ethical concerns, we provided group-based support to participants in the control group after the 6-month intervention period and did not include them in the follow-up measurements. Finally, 125 overweight adults (92 women and 33 men) from the education-only and the group-based support groups (62 and 63 adults, respectively) underwent follow-up. Assuming a two-sided alpha value of 0.05, the number of participants in this study yielded 93% power to detect a group difference of 2.5 ± 4.0 kg in the amount of weight lost at the end of 2-year follow-up. The participants received no financial compensation or gifts. The protocol was approved by the ethical committee of Mito Kyodo General Hospital and by the Institutional Review Board of the University of Tsukuba.

Participants were recruited through newspaper advertisements. The eligibility criteria for the participants included an age of 40-65 years, a BMI of 25-40 kg/m^2^ and the presence of at least one of the following components involved in the diagnosis of metabolic syndrome, according to the Japanese criteria \[[@B17]\]: i) waist circumference ≥ 85 cm in men or ≥ 90 cm in women, ii) systolic blood pressure ≥ 130 mm Hg, iii) diastolic blood pressure ≥ 85 mm Hg, iv) triglyceride level ≥ 150 mg/dl (1.70 mmol/l), v) high-density lipoprotein cholesterol level \< 40 mg/dl (1.04 mmol/l) and vi) fasting plasma glucose level ≥ 110 mg/dl (6.11 mmol/l). The age and BMI ranges were based on the target for active support in the Japanese national intervention programme specifically targeted at metabolic syndrome \[[@B7]\]. The criteria for ineligibility included current or planned pregnancy, past history of coronary disease or stroke, and drug treatment for diabetes to avoid a potential influence on weight change \[[@B9]\]. To avoid a ripple effect on weight loss \[[@B18]\], participants whose cohabiting family member(s) participated in this study were also considered ineligible.

Interventions {#sec2_2}
-------------

After taking the baseline measurements in which the participants were assessed for eligibility, all participants attended a 2-hour, group-based, single motivational lecture conducted by an investigator (YN). The lecture consisted of the introduction of the Japanese national health screening and intervention programme conducted since April 2008 that specifically target at metabolic syndrome \[[@B7]\], combined cardiovascular risk factors and the outcome \[[@B19]\], and the target value for improving metabolic syndrome \[[@B20]\]. The participants also received typical weight control instructions on diet, exercise and behavioural changes. The recommendations included a calorie-restricted diet of 1,200 and 1,600 kcal/day for women and men, respectively \[[@B20],[@B21],[@B22]\] and a minimum of 1,000 kcal/week of increased physical activity \[[@B23]\]. All participants were encouraged to self-monitor their body weight every day.

After the motivational lecture, the participants were randomly assigned to one of the 3 groups using simple randomisation procedures involving computerised random numbers. The allocation data were generated by an investigator (MO) who had no contact with the participants or other staff members, and the data were maintained at a central secure location until completion of the motivational lecture.

At week 1, the participants in the education-only and the group-based support groups attended a group-based, 2-hour session in which they were provided with educational materials such as textbooks and notebooks containing information on daily diet and other lifestyle-related issues. The content of the textbooks and notebooks was based on the prior work of the investigators \[[@B20],[@B24]\]. The dietary programme was based on the Four-Food-Group Point Method \[[@B14],[@B25]\]. Participants in the education-only and the group-based support groups were encouraged to modify their diet according to the information in the provided textbooks and were instructed to record their body weight, the content of meals and the daily step counts in the provided notebook. A pedometer (FB-720; Tanita, Tokyo, Japan) was also provided to motivate the participants to increase their physical activity \[[@B26]\].

The participants in the group-based support group attended a group-based, 2-hour session at weeks 2, 4, 6, 10, 14, 18 and 22. The frequency of support meeting was suggested to be one of the independent predictors of weight change \[[@B9]\]. In the present study, in the initial part of the intervention period, we reduced the frequency of the support meetings from every 2 weeks to every 4 weeks in order to provide the participants information on the basics of changing behaviours. Each group-based support meeting was conducted by 3 staff members who were trained by the investigators (YN and KT). One staff member conducted lectures to explain the content of the textbooks, and 2 other staff members reviewed the participants' notebooks and advised them on their diet and other lifestyle factors at each session.

Outcome Measures {#sec2_3}
----------------

Data were collected at baseline and at months 3, 6, 18 and 30 in the hospital by trained hospital staff members who were blinded to the treatment assignment process.

The primary outcome measure was the amount of weight lost from baseline to 30 months. Wing and Hill \[[@B27]\] defined successful long-term weight loss maintenance as intentionally losing at least 10% of initial body weight and keeping it off for at least 1 year. According to the definition, the authors pre-determined the primary outcome as the 30-month changes from baseline. Weight was measured to the nearest 0.05 kg using a calibrated digital scale (WB-150; Tanita). The participants wore light clothes and no shoes for the weight measurement. Height was measured to the nearest 0.1 cm on a wall-mounted stadiometer at baseline to estimate the BMI.

The secondary outcome measures were waist circumference, systolic and diastolic blood pressures, triglyceride level, high-density lipoprotein cholesterol level and fasting plasma glucose level. The waist circumference was measured to the nearest 0.1 cm at the umbilicus level using a flexible plastic tape, with the participants in the standing position. Blood pressure was measured using a manual sphygmomanometer, with the participants maintained in the seated position after a 20-min rest period. Two readings of systolic and diastolic blood pressures were recorded, and the average value was used for data analysis \[[@B28]\]. Approximately 10 ml of blood was drawn from each participant (between 10:30 and 11:30 am) after a fasting period of more than 12 h. Fresh samples were used for enzymatic analysis of triglycerides, and fasting plasma glucose level was assayed using glucose oxidase. The serum high-density lipoprotein cholesterol level was measured using heparin-manganese precipitation. Venous blood was analysed by an independent laboratory (Kotobiken Medical Laboratories, Ibaraki, Japan).

We measured the energy intake by using 3-day food records and physical activity using an Active style Pro three-axis accelerometer (HJA-350IT; Omron Healthcare, Kyoto, Japan). The participants were asked to record everything they consumed for 3 days, i.e., 2 weekdays and 1 weekend day. Foods were measured using standard measuring cups, spoons and digital scales. To ensure overall comparability, a skilled nutritionist who was blinded to the treatment assignment process analysed all of the food records. Furthermore, the participants were asked to wear the accelerometer on their waists throughout the day for 14 days. The accelerometer counted daily steps and estimated the intensity of physical activity, expressed as metabolic equivalents \[[@B29],[@B30]\]. The devices were not worn when sleeping, while engaged in a water-based activity (e.g., bathing or swimming) or while participating in activities such as contact sports for safety reasons. Records obtained were defined as valid when a device was worn for at least 10 h/day \[[@B31]\]. If no acceleration signal was obtained over a 10-second time interval for 20 consecutive min or more, the period was defined as 'non-wear' \[[@B32]\]. When valid records were collected for more than 2 weekdays and 1 weekend day, we calculated the mean of the daily step counts and the total daily minutes of moderate-to-vigorous (≥3 metabolic equivalents) physical activity (MVPA).

Statistical Analysis {#sec2_4}
--------------------

The purpose of the initial part (6 months) of the present RCT was to examine the effectiveness of education-only and groups-based support using controls. Our previous study \[[@B14]\] used an intention-to-treat analysis, with the missing data replaced by the last observation carried forward. In the present follow-up study, we aimed at comparing the amount of weight lost from baseline to the end of follow-up in the education-only and the group-based support groups. Thus, an intention-to-treat analysis, with the missing data replaced by baseline observation carried forward, was applied to the measures of body weight and related outcome variables. An unpaired t test was used to examine the statistical significance of between-group differences, and a χ^2^ test was used to compare proportions. The participants were retrospectively grouped into quartiles of percent changes of initial body weight from baseline to the end of follow-up for secondary analyses, in order to explore the success factors for weight loss maintenance. Differences among the quartiles were examined using one-way analysis of variance for continuous variables and χ^2^ test for categorical variables. Data were analysed using IBM SPSS Statistics 20 (SPSS Inc., Chicago, IL, USA), with the level of statistical significance set at 5%.

Results {#sec1_3}
=======

Participants {#sec2_5}
------------

Figure [1](#F1){ref-type="fig"} shows the number of participants through the course of the study. We recruited 222 participants between November 2008 and March 2009 and assessed 213 participants for eligibility (9 did not attend). After excluding 25 ineligible participants, 188 adults (145 women and 43 men) were enrolled in the intervention phase. After the intervention phase, participants in the education-only and the group-based support groups were followed up for 2 years. Table [1](#T1){ref-type="table"} provides the baseline characteristics of the followed-up participants. Significant group differences were observed in the number of participants who were receiving lipid-lowering therapy and in the triglyceride levels. The attrition rates were 9.6% (12/125) and 20.0% (25/125) at months 18 and 30, respectively (fig. [1](#F1){ref-type="fig"}). The numbers of individuals lost to follow-up at 30 months were similar in both groups (p = 0.531). The medical reasons for attrition during 30 months included menopausal syndrome and hysteromyoma that developed during the intervention phase. One participant died during the follow-up period, but the cause was not confirmed. No clinically significant adverse events related to participation in the trial occurred, as judged by the investigators.

Intention-to-Treat Analyses {#sec2_6}
---------------------------

The pattern of weight change is shown in figure [2](#F2){ref-type="fig"}. The mean weight loss during the 6-month intervention phase in the education-only and the group-based support groups was 4.7 kg (95% CI 3.7-5.7 kg) and 7.7 kg (95% CI 6.7-8.8 kg) respectively. The weight difference between the 2 groups reduced by half at 1 year (3.0 kg at 6 months to 1.5 kg at the 1 year) and disappeared at 2 years (0.0 kg; 95% CI −1.7 to 1.8 kg). Table [2](#T2){ref-type="table"} shows changes in the secondary outcome measures, energy intake and physical activity. Most values (weight, BMI, waist circumference, systolic and diastolic blood pressures, high-density lipoprotein cholesterol level and energy intake) improved at 30 months as compared to the baseline values in each group, whereas no significant differences were observed between the 2 groups with respect to all variables. The stratified analysis by gender showed consistent results (data not shown).

Secondary Analyses {#sec2_7}
------------------

100 participants who completed the 30-month assessment were retrospectively grouped into quartiles of percent weight loss from baseline to the end of follow-up for secondary analyses (table [3](#T3){ref-type="table"}). Baseline characteristics were not significantly different among the groups. Significant differences were observed in 30-month changes in waist circumference, systolic blood pressure, triglyceride level and high-density lipoprotein cholesterol level. The participants in the 4th quartile group who accomplished the most successful weight loss maintenance increased their step counts by 2,607 steps, which was higher than that observed in the other groups (p \< 0.05 by Bonferroni\'s post hoc test). They also increased their MVPA by 21 min/day, which was higher than that in the 1st and 3rd quartile groups (p \< 0.05 by Bonferroni\'s post hoc test). In contrast to physical activity, 30-month changes in energy intake were not significantly different among the groups (p = 0.602).

Discussion {#sec1_4}
==========

The initial part of the present RCT (6-month intervention period) revealed that group-based support is an effective method for promoting weight loss on a short-term basis. However, the present follow-up study revealed that the short-term effects disappeared after a 2-year non-intervention period.

A meta-analysis of changes in BMI after the weight loss phase suggests a regain of approximately 0.02-0.03 kg/m^2^ per month during the maintenance phase \[[@B9]\]. The present study involved a 2-year (24-month) follow-up period. Accordingly, a regain of 0.48-0.72 kg/m^2^ was estimated. In fact, the BMI of participants in the education-only group increased by 0.5 kg/m^2^ during the maintenance phase, which approximately equalled the estimated value. On the other hand, the BMI of the group-based support group increased by 1.7 kg/m^2^ during the maintenance phase. The regain in the group-based support group was approximately 3 times greater than that in the education-only group.

From the abovementioned data, it is evident that the group-based support was not effective after the 2-year follow-up period. This could be because group-based support appears to allow participants to interact with each other and provides short-term benefits in terms of achieving weight loss \[[@B33]\]. Further, the staff members motivated the participants. Although this is a strength of group-based support, it turns into a weakness if the programme is not continued. The intensive support might increase dependence on the staff members, and the participants become prone to regaining weight. Therefore, the implementation of weight maintenance programmes after a group-based weight loss intervention might be essential to achieve successful weight loss maintenance.

The secondary analyses in the present study revealed that the participants who successfully maintained their weight loss over 30 months (highest quartile of percent weight loss) increased their step counts (2,607 steps/day) significantly more than those in the other groups (1st to 3rd quartiles). Furthermore, participants in the highest quartile group spent much more time in MVPA (21 min/day) than those in the 1st and 3rd quartile groups. Conversely, no significant difference was observed in the change in energy intake among the groups. These results suggest that increasing physical activity may be a crucial factor for successfully maintaining weight loss.

The American College of Sports Medicine Position Stand \[[@B34]\] recommended 250 min/week of physical activity for weight loss maintenance. However, the position stand also stated that no evidence from well-designed RCTs exists to judge the effectiveness of physical activity for prevention of weight regain after weight loss. A few previous studies facilitating maintenance of weight loss by focusing on increasing physical activity \[[@B35],[@B36]\] concluded that the prescribed physical activity intervention did not influence the weight loss outcomes, but post hoc analysis showed that individuals sustaining successful weight loss performed more physical activity. Although improving adherence to the prescribed physical activity interventions is difficult, the effectiveness of increasing physical activity during the weight maintenance phase should be closely examined in future studies.

The major strength of this study is that it was a carefully designed long-term RCT with a relatively good retention rate. This study also had a few limitations. First, the study population included only Japanese participants, aged 40-65 years, who were willing and motivated, which limits the generalisation of the results. Additionally, most participants were women. Second, we could not follow up the control group of the initial part of the present RCT due to ethical concerns. Moreover, the attrition rate was 20.0% at 30 months. Although this figure is modest, an intention-to-treat analysis would have produced overly conservative results in hypothesis testing. Finally, secondary analyses suggest that increasing physical activity may be effective in successfully maintaining weight loss; however, RCTs are needed to demonstrate the effectiveness of the concept.

In conclusion, group-based support is an effective method for promoting weight loss on a short-term basis, but the effect disappears in the absence of weight maintenance programmes. For successful weight loss maintenance, additional approaches during the weight maintenance phase are necessary. Increasing physical activity may be crucial for successfully maintaining weight loss. Further RCTs are required to show that increasing physical activity can contribute to weight loss maintenance.
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###### 

Baseline characteristics of followed-up participants by treatment assignment[^a^](#T1F1){ref-type="table-fn"}

                                                           Education-only (n = 62)   Group-based support (n = 63)   p-value[^b^](#T1F2){ref-type="table-fn"}
  -------------------------------------------------------- ------------------------- ------------------------------ ------------------------------------------
  Age, years                                               51.7 (6.8)                50.7 (6.7)                     0.414
  Women, no. (%)                                           41 (66)                   51 (81)                        0.059
  Current smoker, no. (%)                                  3 (5)                     3 (5)                          0.984
  Lipid-lowering therapy, no. (%)                          10 (16)                   3 (5)                          0.033
  Antihypertensive therapy, no. (%)                        16 (26)                   15 (24)                        0.796
  Height, cm                                               160.0 (9.0)               159.1 (7.2)                    0.577
  Weight, kg                                               74.9 (12.1)               73.5 (9.9)                     0.476
  BMI, kg/m^2^                                             29.2 (3.8)                29.0 (3.0)                     0.670
  Waist circumference, cm                                  100.7 (7.9)               99.2 (7.3)                     0.269
  Systolic blood pressure, mm Hg                           131.2 (14.5)              131.9 (16.4)                   0.793
  Diastolic blood pressure, mm Hg                          80.2 (7.4)                79.9 (10.2)                    0.849
  Triglycerides, mmol/l                                    1.57 (0.71)               1.26 (0.59)                    0.009
  HDL cholesterol, mmol/l                                  1.39 (0.34)               1.49 (0.31)                    0.093
  Fasting plasma glucose, mmol/l                           5.50 (0.96)               5.25 (0.59)                    0.079
  Energy intake, kcal/day                                  2,181 (417)               2,169 (414)                    0.880
  Step counts, step/day[^c^](#T1F3){ref-type="table-fn"}   6,198 (2,740)             6,435 (3,016)                  0.650
  MVPA, min/day[^c^](#T1F3){ref-type="table-fn"}           86 (30)                   93 (35)                        0.191

HDL = High-density lipoprotein; MVPA = moderate-to-vigorous physical activity.

Data are presented as mean (standard deviation) unless otherwise specified.

p value of unpaired *t-*test or χ^2^ test at baseline between groups.

Data from 123 eligible participants were available (61 and 62 in the education-only and the group-based support groups, respectively).

###### 

Changes in primary and secondary outcome measures, energy intake, and physical activity by intention-to-treat analysis[^a^](#T2F1){ref-type="table-fn"}

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                           Education-only (n = 62)   Group-based support (n = 63)   p-value[^b^](#T2F2){ref-type="table-fn"}                                                                                       
  -------------------------------------------------------- ------------------------- ------------------------------ ------------------------------------------ ------------------ --------------- --------------- -------------- ----------------- -------
  Weight, kg                                               74.9 (12.1)               70.2 (12.6)                    71.6 (12.5)                                −3.3\              73.5 (9.9)      65.7 (9.5)      70.2 (10.6)    −3.3\             0.967
                                                                                                                                                               (−4.7 to −1.9)                                                    (−4.4 to −2.2)    

                                                                                                                                                                                                                                                   

  BMI, kg/m^2^                                             29.2 (3.8)                27.4 (4.0)                     28.0 (4.0)                                 −1.3\              29.0 (3.0)      25.9 (3.0)      27.7 (3.5)     −1.3\             0.945
                                                                                                                                                               (−1.8 to −0.7)                                                    (−1.7 to −0.9)    

                                                                                                                                                                                                                                                   

  WC, cm                                                   100.7 (7.9)               96.0 (9.1)                     96.1 (9.1)                                 −4.6\              99.2 (7.3)      91.1 (8.4)      94.3 (8.5)     −4.9\             0.773
                                                                                                                                                               (−6.1 to −3.0)                                                    (−6.3 to −3.4)    

                                                                                                                                                                                                                                                   

  SBP, mm Hg                                               131.2 (14.5)              120.5 (13.3)                   124.3 (13.3)                               −6.9\              131.9 (16.4)    119.6 (18.1)    126.4 (17.5)   −5.5\             0.530
                                                                                                                                                               (−10.1 to −3.7)                                                   (−8.6 to −2.3)    

                                                                                                                                                                                                                                                   

  DBP, mm Hg                                               80.2 (7.4)                73.2 (9.1)                     74.9 (8.1)                                 −5.3\              79.9 (10.2)     71.3 (9.7)      76.0 (10.3)    −3.9\             0.322
                                                                                                                                                               (−7.3 to −3.3)                                                    (−5.9 to −1.8)    

                                                                                                                                                                                                                                                   

  TG, mmol/l                                               1.57 (0.71)               1.23 (0.68)                    1.36 (0.70)                                −0.21\             1.26 (0.59)     0.95 (0.43)     1.20 (0.65)    −0.06\            0.113
                                                                                                                                                               (−0.35 to −0.07)                                                  (−0.18 to 0.06)   

                                                                                                                                                                                                                                                   

  HDL−C, mmol/l                                            1.39 (0.34)               1.44 (0.35)                    1.49 (0.39)                                0.10\              1.49 (0.31)     1.56 (0.35)     1.55 (0.38)    0.06\             0.378
                                                                                                                                                               (0.04 to 0.17)                                                    (0.00 to 0.13)    

                                                                                                                                                                                                                                                   

  FPG, mmol/l                                              5.50 (0.96)               5.16 (0.82)                    5.36 (0.90)                                −0.14\             5.25 (0.59)     4.91 (0.38)     5.23 (0.56)    −0.01\            0.084
                                                                                                                                                               (−0.29 to −0.01)                                                  (−0.08 to 0.06)   

                                                                                                                                                                                                                                                   

  Energy intake, kcal/day                                  2,181 (417)               1,799 (440)                    1,983 (416)                                −197\              2,169 (414)     1,524 (354)     1,918 (396)    −251\             0.384
                                                                                                                                                               (−285 to −110)                                                    (−339 to −163)    

                                                                                                                                                                                                                                                   

  Step counts, step/day[^c^](#T2F3){ref-type="table-fn"}   6,198 (2,740)             7,468 (3,676)                  6,890 (3,455)                              692\               6,435 (3,016)   7,525 (3,326)   6,916 (4310)   481\              0.667
                                                                                                                                                               (215 to 1,170)                                                    (−367 to 1,330)   

                                                                                                                                                                                                                                                   

  MVPA, min/day[^c^](#T2F3){ref-type="table-fn"}           86 (30)                   96 (37)                        90 (38)                                    5\                 93 (35)         99 (37)         95 (45)        2\                0.565
                                                                                                                                                               (−1 to 11)                                                        (−6 to 10)        
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

DBP = Diastolic blood pressure; FPG = fasting plasma glucose; HDL-C = high-density lipoprotein cholesterol; MVPA = moderate-to-vigorous physical activity; SBP =systolic blood pressure; TG = triglycerides; WC = waist circumference.

Data at baseline and months 6 and 30 are presented as mean (standard deviation). Changes from baseline to month 30 are presented as mean (95% confidence interval).

p value of unpaired t-test for 30-month change between groups.

Data from 123 eligible participants were available (61 and 62 in the education-only and the group-based support groups, respectively).

###### 

Baseline characteristics and changes in outcome measures based on quartiles of percent weight loss^a^

                                      Percent weight loss at 30 months   p-value^b^                                       
  ----------------------------------- ---------------------------------- --------------- --------------- ---------------- ---------
  Age, years                          50.6 (6.6)                         51.3 (7.0)      52.4 (7.9)      51.0 (6.2)       0.813
  Women, no. (%)                      16 (64)                            21 (84)         20 (80)         16 (64)          0.230
  Group-based support, no. (%)        10 (40)                            14 (56)         12 (48)         13 (52)          0.704
  Current smoker, no. (%)             1 (4)                              1 (4)           2 (8)           0 (0)            0.414
  Lipid-lowering therapy, no. (%)     2 (8)                              3 (12)          4 (16)          2 (8)            0.778
  Antihypertensive therapy, no. (%)   5 (20)                             8 (32)          6 (24)          4 (16)           0.582
  Height, cm                          162.1 (9.7)                        157.5 (5.8)     157.5 (6.6)     161.4 (8.2)      0.074
  Weight, kg                                                                                                              
   Baseline                           75.0 (12.8)                        73.0 (8.2)      74.1 (12.0)     74.3 (10.6)      0.931
   Changes                            +1.4 (1.6)                         −1.8 (0.7)      −5.0 (1.8)      −10.9 (4.2)      \<0.001
  BMI, kg/m^2^                                                                                                            
   Baseline                           28.4 (2.9)                         29.4 (3.7)      29.8 (3.9)      28.4 (2.3)       0.312
   Changes                            +0.5 (0.6)                         −0.7 (0.2)      −2.0 (0.6)      −4.2 (1.5)       \<0.001
  WC, cm                                                                                                                  
   Baseline                           99.4 (7.0)                         100.2 (8.8)     101.8 (7.8)     98.8 (5.3)       0.500
   Changes                            −0.4 (4.4)                         −3.6 (3.1)      −7.4 (3.3)      −12.1 (5.2)      \<0.001
  SBP, mm Hg                                                                                                              
   Baseline                           128.5 (16.6)                       132.6 (12.7)    136.3 (16.5)    129.3 (13.3)     0.242
   Changes                            −4.7 (9.9)                         −3.2 (14.9)     −11.0 (14.4)    −12.0 (13.0)     0.045
  DBP, mm Hg                                                                                                              
   Baseline                           78.2 (8.2)                         80.9 (7.6)      79.8 (7.7)      80.2 (9.2)       0.686
   Changes                            −4.2 (7.9)                         −5.7 (9.6)      −4.4 (7.3)      −8.7 (8.9)       0.222
  TG, mmol/l                                                                                                              
   Baseline                           1.57 (0.80)                        1.29 (0.51)     1.34 (0.50)     1.45 (0.63)      0.397
   Changes                            −0.08 (0.52)                       +0.00 (0.51)    −0.07 (0.58)    −0.52 (0.58)     0.004
  HDL-C, mmol/l                                                                                                           
   Baseline                           1.41 (0.32)                        1.49 (0.28)     1.48 (0.28)     1.41 (0.40)      0.738
   Changes                            +0.02 (0.21)                       +0.00 (0.18)    +0.04 (0.24)    +0.36 (0.30)     \<0.001
  FPG, mmol/l                                                                                                             
   Baseline                           5.28 (0.90)                        5.34 (0.58)     5.62 (1.13)     5.31 (0.65)      0.460
   Changes                            +0.03 (0.30)                       −0.09 (0.37)    −0.07 (0.56)    −0.27 (0.63)     0.191
  Energy intake, kcal/day                                                                                                 
   Baseline                           2,189 (467)                        2,082 (321)     2,118 (318)     2,223 (488)      0.602
   Changes                            −226 (443)                         −219 (274)      −331 (386)      −345 (352)       0.492
  Step counts, step/day^c^                                                                                                
   Baseline                           6,210 (2,748)                      6,784 (2,727)   6,167 (3,076)   6,925 (3,516)    0.752
   Changes                            −33 (1,142)                        +379 (2,924)    +65 (2,705)     +2,607 (4,000)   0.005
  MVPA, min/day^c^                                                                                                        
   Baseline                           87 (33)                            93 (28)         91 (36)         94 (35)          0.883
   Changes                            −4 (18)                            +5 (28)         −3 (30)         +21 (41)         0.018

DBP = Diastolic blood pressure; FPG = fasting plasma glucose; HDL-C = high-density lipoprotein cholesterol; MVPA = moderate-to-vigorous physical activity; SBP = systolic blood pressure; TG = triglycerides; WC= waist circumference.

Data are presented as mean (standard deviation) unless otherwise specified.

p value of one-way analysis of variance or χ^2^ test among groups.

Data from 97 eligible participants were available (25, 25, 23 and 24 in the 1st, 2nd, 3rd, and 4th quartile groups, respectively).
